Alnaqeeb S, Kheder D, Abotaiban N
Cureus. 2025; 17(2):e78810.
PMID: 40078267
PMC: 11902914.
DOI: 10.7759/cureus.78810.
Wang Y, Su Y, Zhang J, Zhou Z, Zhao Y, He S
Exp Ther Med. 2025; 29(4):74.
PMID: 40012919
PMC: 11862799.
DOI: 10.3892/etm.2025.12824.
Milovanova A, Ananin P, Vashurina T, Zrobok O, Dmitrienko S, Ryaposova A
Int J Mol Sci. 2025; 26(4).
PMID: 40004207
PMC: 11855709.
DOI: 10.3390/ijms26041744.
Edelbach B, Lopez-Gonzalez M
Neurosurg Pract. 2025; 6(1):e00126.
PMID: 39958483
PMC: 11809957.
DOI: 10.1227/neuprac.0000000000000126.
Liu Y, Yuan K, Zou L, Lei C, Xu R, He S
BMC Immunol. 2025; 26(1):6.
PMID: 39948449
PMC: 11823220.
DOI: 10.1186/s12865-025-00686-8.
Serum Creatine Levels as a Predictive Factor for Postoperative Cerebrovascular Events in Patients With Moyamoya Disease.
Mou S, Zhao Z, Liu C, Li J, He Q, Liu W
Brain Behav. 2025; 15(2):e70331.
PMID: 39935209
PMC: 11814481.
DOI: 10.1002/brb3.70331.
Research progress in unilateral moyamoya disease.
Hao X, Tan C, Liu Z, Tie Y, Wang Y, He S
Front Hum Neurosci. 2025; 19:1503639.
PMID: 39931047
PMC: 11807984.
DOI: 10.3389/fnhum.2025.1503639.
Low hemoglobin is associated with postoperative cerebral infarction in moyamoya disease: development of a predictive model based on low hemoglobin.
Wu H, Wang T, Li F, Bao Y, Lu B, Li L
Front Neurol. 2025; 15():1489430.
PMID: 39839859
PMC: 11746082.
DOI: 10.3389/fneur.2024.1489430.
Advances in moyamoya disease: pathogenesis, diagnosis, and therapeutic interventions.
He S, Zhou Z, Cheng M, Hao X, Chiang T, Wang Y
MedComm (2020). 2025; 6(2):e70054.
PMID: 39822761
PMC: 11733107.
DOI: 10.1002/mco2.70054.
Intra-individual comparison of long-term outcomes between combined and indirect bypass surgery in adult moyamoya disease.
Chung Y, Kim J, Kang H, Kim T, Paeng J, Cho W
Acta Neurochir (Wien). 2025; 167(1):7.
PMID: 39786449
PMC: 11717893.
DOI: 10.1007/s00701-024-06391-6.
Multiple burr hole and erythropoietin combination therapy: optimal early surgical intervention for patients with acute stroke episode of moyamoya disease or moyamoya syndrome.
Lee Y, Lee J, Lee S, Hong J, Lim Y
Front Neurol. 2025; 15:1479379.
PMID: 39764293
PMC: 11700813.
DOI: 10.3389/fneur.2024.1479379.
Impact of RNF213 p.R4810K variant on postoperative temporal muscle swelling used in encephalo-myo-synangiosis after combined revascularization for Moyamoya disease.
Mizushima M, Ito M, Uchino H, Sugiyama T, Fujimura M
Neurosurg Rev. 2024; 48(1):15.
PMID: 39738728
DOI: 10.1007/s10143-024-03165-7.
Cognitive dysfunction in Moyamoya disease: latest developments and future directions.
Wang X, Liu Z, Zhou Z, Zhang J, Wang Y, He S
Front Hum Neurosci. 2024; 18:1502318.
PMID: 39713171
PMC: 11659249.
DOI: 10.3389/fnhum.2024.1502318.
Comparing Outcomes of Moyamoya Disease and Moyamoya Syndrome in a Real-World Scenario: A Cohort Study.
Wang X, Li J, Wang Q, Gao G, Yu D, Zhang Q
CNS Neurosci Ther. 2024; 30(12):e70165.
PMID: 39654371
PMC: 11628736.
DOI: 10.1111/cns.70165.
Angiographic features and progression risk factors in children with asymptomatic moyamoya disease.
Wang J, Zhang Q, Di F, Zhang D
Front Neurol. 2024; 15:1484132.
PMID: 39618838
PMC: 11604640.
DOI: 10.3389/fneur.2024.1484132.
Analysis of Optic Disc Morphology and the Peripapillary Retinal and Choroidal Thickness by the Swept Source Optical Coherence Tomography in Patients with Moyamoya Disease.
Yang F, Li X, Wang X, Chen X, Niu Y, Zhang Y
Ophthalmic Res. 2024; 68(1):61-70.
PMID: 39586258
PMC: 11844671.
DOI: 10.1159/000542801.
Risk Factors and Characteristics Associated with Visual Impairment and Eye Diseases in Moyamoya Disease: Insights from a National Database.
Song Y, Yang X, Yang H, Mei H, Lu X, Xie H
Ophthalmol Ther. 2024; 14(1):183-196.
PMID: 39579253
PMC: 11724827.
DOI: 10.1007/s40123-024-01052-4.
Aneurysmal formation of periventricular anastomosis is associated with collateral development of Moyamoya disease and its rupture portends poor prognosis: detailed analysis by multivariate statistical and machine learning approaches.
Sato D, Miyawaki S, Torazawa S, Imai H, Hongo H, Kiyofuji S
Neurosurg Rev. 2024; 47(1):856.
PMID: 39557727
PMC: 11573815.
DOI: 10.1007/s10143-024-03097-2.
Prognostic value of morphology and hemodynamics in moyamoya disease for long-term outcomes and disease progression.
Ma L, Ge P, Zeng C, Liu C, Yin Z, Ya X
Sci Rep. 2024; 14(1):28182.
PMID: 39548256
PMC: 11568140.
DOI: 10.1038/s41598-024-79608-4.
Orofacial features and dental management of a pediatric patient with moyamoya disease-A one year follow up.
AlHarbi S, Bhadila G, Almushayt A
Clin Case Rep. 2024; 12(11):e9502.
PMID: 39479587
PMC: 11521935.
DOI: 10.1002/ccr3.9502.
